Publication:
Preclinical studies evaluating the therapeutic efficacy of novel natural compound olean-12-en-28-ol, 3β pentacosanoate for multiple sclerosis

Thumbnail Image

relationships.isOrgUnitOf

Program

relationships.isAuthorOf

Author




Eken A.

Acar B.

Aktaş Pepe N.

Güner H.

Aykut Z. G.

Çevik Kaplan S.

Ayaz Güner Ş.

Advisor

Date

2022-09-26

Language

Type

conferenceObject

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Description

Source

Keywords

Keywords

Yaşam Bilimleri , Moleküler Biyoloji ve Genetik , Temel Bilimler , Life Sciences , Molecular Biology and Genetics , Natural Sciences , Temel Bilimler (SCI) , Yaşam Bilimleri (LIFE) , Doğa Bilimleri Genel , ÇOK DİSİPLİNLİ BİLİMLER , Natural Sciences (SCI) , Life Sciences (LIFE) , NATURAL SCIENCES, GENERAL , MOLECULAR BIOLOGY & GENETICS , MULTIDISCIPLINARY SCIENCES , Moleküler Biyoloji , Multidisipliner , Molecular Biology , Multidisciplinary

Citation

Şenol H., Özgün-Acar Ö., Dağ A., Eken A., Acar B., Aktaş Pepe N., Güner H., Aykut Z. G., Çevik Kaplan S., Ayaz Güner Ş., et al., \"Preclinical studies evaluating the therapeutic efficacy of novel natural compound olean-12-en-28-ol, 3β pentacosanoate for multiple sclerosis\", I. International Advances in Molecular Biology Congress, İstanbul, Türkiye, 19 - 22 Eylül 2022, ss.55-56

URI

https://hdl.handle.net/20.500.12645/37115

Collections

Yayınlar - Eserler

Endorsement

Review

Supplemented By

Referenced By

11

Views

0

Downloads


Sustainable Development Goals